Stryker Corporation

Curis, Inc.

Slobodon Vukicevic

Charles M Cohen

Kuber T Sampath

The present invention provides methods for the treatment, and pharmaceuticals for use in the treatment, of mammalian subjects in, or at risk of chronic renal failure, or at risk of a need for renal replacement therapy. The methods involve the administration of certain proteins of, or based upon, the osteogenic protein/bone morphogenetic protein (OP/BMP) family within the TGF-&#x3b2; superfamily of proteins.

Therapies for chronic renal failure

The present invention provides methods for the treatment, and pharmaceuticals for use in the treatment, of mammalian subjects in, or at risk of chronic renal failure, or at risk of a need for renal replacement therapy. The methods involve the administration of certain proteins of, or based upon, the osteogenic protein/bone morphogenetic protein (OP/BMP) family within the TGF-&#x3b2;superfamily of proteins.

Growing community of inventors

Zagreb, Croatia

Slobodon Vukicevic